Literature DB >> 8443910

Adenosine alters glucose use during ischemia and reperfusion in isolated rat hearts.

B A Finegan1, G D Lopaschuk, C S Coulson, A S Clanachan.   

Abstract

BACKGROUND: Adenosine possesses marked cardioprotective properties, but the mechanisms for this beneficial effect are unclear. The objective of this study was to determine the effect of adenosine given before ischemia or at reperfusion on mechanical function, glucose oxidation, glycolysis, and metabolite levels in isolated, paced (280 beats per minute) working rat hearts. METHODS AND
RESULTS: Hearts were perfused with Krebs-Henseleit buffer containing 11 mM glucose, 1.2 mM palmitate, and 500 microU.mL-1 insulin at an 11.5 mm Hg left atrial preload and 80 mm Hg aortic afterload. Adenosine (100 microM) pretreatment or adenosine (100 microM) at reperfusion markedly increased the recovery of mechanical function (from 44% to 81% and 96%, respectively) after 60 minutes of low-flow ischemia (coronary flow, 0.5 mL.min-1). Glucose oxidation (mumol.min-1 x g dry wt-1) was inhibited during ischemia (from 0.44 +/- 0.04 to 0.12 +/- 0.01), and this was not altered by adenosine (100 microM). During reperfusion, glucose oxidation recovered (to 0.38 +/- 0.02) and adenosine (100 microM), given at reperfusion, further increased glucose oxidation (to 0.52 +/- 0.06). The rate of glycolysis (mumol.min-1 x g dry wt-1), which was unaffected by ischemia per se, was inhibited by adenosine pretreatment (from 4.7 +/- 0.3 to 2.6 +/- 0.3). During reperfusion, glycolysis was also inhibited by adenosine relative to control (3.9 +/- 0.8) either when present during ischemia (2.6 +/- 0.6) or during reperfusion (1.4 +/- 0.4). These effects of adenosine on glucose metabolism reduced the calculated rate of H+ production attributable to glucose metabolism during the ischemic and reperfusion periods. Tissue lactate levels (mumol.g dry wt-1), which increased during ischemia (from 9.3 +/- 1.1 to 87.4 +/- 10.3) and then declined during reperfusion (to 26.2 +/- 3.7), were depressed further by adenosine pretreatment (to 19.7 +/- 4.1) and by adenosine at reperfusion (to 13.6 +/- 2.1). ATP levels (mumol.g dry wt-1), which were depressed by ischemia (from 18.1 +/- 1.1 to 10.6 +/- 1.3) and tended to be further depressed during reperfusion (to 7.1 +/- 0.7), were increased by adenosine pretreatment (to 14.1 +/- 1.2) and by adenosine at reperfusion (to 15.6 +/- 2.4).
CONCLUSIONS: The effects of adenosine on glucose metabolism that would tend to decrease cellular acidosis and hence, Ca2+ overload, may explain the beneficial effects of adenosine on mechanical function observed in these hearts during reperfusion after ischemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443910     DOI: 10.1161/01.cir.87.3.900

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  Loss of glycogen during preconditioning is not a prerequisite for protection of the rabbit heart.

Authors:  C Weinbrenner; P Wang; J M Downey
Journal:  Basic Res Cardiol       Date:  1996 Sep-Oct       Impact factor: 17.165

2.  Alteration of glycogen and glucose metabolism in ischaemic and post-ischaemic working rat hearts by adenosine A1 receptor stimulation.

Authors:  H Fraser; G D Lopaschuk; A S Clanachan
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

3.  Modulation of cardiac A1-adenosine receptors in rats following treatment with agents affecting heart rate.

Authors:  Nissim Balas; Michael Arad; Babeth Rabinowitz; Asher Shainberg
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

4.  Influence of beta-adrenoceptor tone on the cardioprotective efficacy of adenosine A(1) receptor activation in isolated working rat hearts.

Authors:  W R Ford; B I Jugdutt; G D Lopaschuk; R Schulz; A S Clanachan
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

5.  Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model.

Authors:  Angelical S Martin; Dennis M Abraham; Kathleen A Hershberger; Dhaval P Bhatt; Lan Mao; Huaxia Cui; Juan Liu; Xiaojing Liu; Michael J Muehlbauer; Paul A Grimsrud; Jason W Locasale; R Mark Payne; Matthew D Hirschey
Journal:  JCI Insight       Date:  2017-07-20

6.  Inhibition of glycolysis and enhanced mechanical function of working rat hearts as a result of adenosine A1 receptor stimulation during reperfusion following ischaemia.

Authors:  B A Finegan; G D Lopaschuk; M Gandhi; A S Clanachan
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

7.  Ischemia-reperfusion injury leads to distinct temporal cardiac remodeling in normal versus diabetic mice.

Authors:  Megumi Eguchi; Young Hwa Kim; Keon Wook Kang; Chi Young Shim; Yangsoo Jang; Thierry Dorval; Kwang Joon Kim; Gary Sweeney
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

8.  Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia.

Authors:  Tobias Eckle; Katherine Hartmann; Stephanie Bonney; Susan Reithel; Michel Mittelbronn; Lori A Walker; Brian D Lowes; Jun Han; Christoph H Borchers; Peter M Buttrick; Douglas J Kominsky; Sean P Colgan; Holger K Eltzschig
Journal:  Nat Med       Date:  2012-04-15       Impact factor: 53.440

Review 9.  Glucose Metabolism in Cardiac Hypertrophy and Heart Failure.

Authors:  Diem H Tran; Zhao V Wang
Journal:  J Am Heart Assoc       Date:  2019-06-12       Impact factor: 5.501

10.  Low-dose adenosine stress echocardiography: detection of myocardial viability.

Authors:  Ana Djordjevic-Dikic; Miodrag Ostojic; Branko Beleslin; Ivana Nedeljkovic; Jelena Stepanovic; Sinisa Stojkovic; Zorica Petrasinovic; Milan Nedeljkovic; Jovica Saponjski; Vojislav Giga
Journal:  Cardiovasc Ultrasound       Date:  2003-06-03       Impact factor: 2.062

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.